Ownership history in UBS Group AG · 1 quarter on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in APIMEDS PHARMACEUTICALS US I (APUS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | INITIATED | 582 | — | — | 0.00% | $954 | $1.64 |
As of 2025 Q4 — sorted by position size